Dec 13, 2023, 11:08
Genentech Welcomes Ashley Magargee as New CEO: A 20-Year Journey of Excellence and Leadership
Genentech shared today on LinkedIn:
“We are excited to share that Ashley Magargee has been appointed our Chief Executive Officer effective January 1, 2024.
Most recently Head of Commercial Portfolio, Ashley is a 20-year Roche and Genentech veteran with a deep commitment to our people, the patients we serve, and the stakeholders with whom we partner across the healthcare system.
Read more below. Congratulations, Ashley!”
More information here: https://www.gene.com/media/statements/ps_121223
Source: Genentech / LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 20, 2024, 16:38
Nov 20, 2024, 16:24
Nov 20, 2024, 16:12
Nov 20, 2024, 15:55
Nov 20, 2024, 15:43
Nov 20, 2024, 15:40